Contribute Try STAT+ Today

For the second time in the past year, the lower house of the Chilean congress passed a resolution instructing the government to make it possible to issue compulsory licenses for medicines, but this time, the effort is focused specifically on hepatitis C treatments.

The move comes in response to concerns over rising prices and the ability of the government to cover costs, according to the resolution, and follows a move last month by more than two dozen advocacy groups from around the world to press the health ministry to take action.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Forgive stupid question, but why is no login for my Stat+ subscription possible on Safari on my iPad? Seriously, nowhere on page is there a log-in. Browsers on laptop all work fine but not ipad. Thanks for any help.

Comments are closed.

Your daily dose of news in health and medicine

Privacy Policy